Microbiome influencers of checkpoint blockade-associated toxicity.
Microbiome influencers of checkpoint blockade-associated toxicity.
复制标题
DOI:
10.1084/jem.20220948
复制
发表时间:
2023-03-06
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
The microbiome influences response to immunotherapy, including immune-related adverse events (irAEs) with checkpoint inhibitors. Wang, Jenq, et al. discuss microbiome contributions to irAEs by focusing on major bacterial taxa, potential immune mechanisms, and clinical opportunities for microbiome modulation to treat irAEs. Immunotherapy has greatly improved cancer outcomes, yet variability in response and off-target tissue damage can occur with these treatments, including immune checkpoint inhibitors (ICIs). Multiple lines of evidence indicate the host microbiome influences ICI response and risk of immune-related adverse events (irAEs). As the microbiome is modifiable, these advances indicate the potential to manipulate microbiome components to increase ICI success. We discuss microbiome features associated with ICI response, with focus on bacterial taxa and potential immune mechanisms involved in irAEs, and the overall goal of driving novel approaches to manipulate the microbiome to improve ICI efficacy while avoiding irAE risk.
登录
查看更多内容
影响因子:
30.3
作者:
Cao, Y. Grace;Bae, Sena;Villarreal, Jannely;Moy, Madelyn;Chun, Eunyoung;Michaud, Monia;Lang, Jessica K.;Glickman, Jonathan N.;Lobel, Lior;Garrett, Wendy S.
通讯作者:
Garrett, Wendy S.
影响因子:
64.5
作者:
Ang, Qi Yan;Alexander, Margaret;Turnbaugh, Peter J.
通讯作者:
Turnbaugh, Peter J.
影响因子:
4.6
作者:
Chang CC;Hayase E;Jenq RR
通讯作者:
Jenq RR
影响因子:
16.6
作者:
Dubin K;Callahan MK;Ren B;Khanin R;Viale A;Ling L;No D;Gobourne A;Littmann E;Huttenhower C;Pamer EG;Wolchok JD
通讯作者:
Wolchok JD
影响因子:
16.6
作者:
Burrello, Claudia;Garavaglia, Federica;Facciotti, Federica
通讯作者:
Facciotti, Federica